Management of Prolonged Bleeding on Progestin-Only Pills

Understanding the Clinical Context

Office endometrial biopsies have a false-negative rate of approximately 10% in patients with abnormal uterine bleeding, according to the National Comprehensive Cancer Network 2
A negative biopsy does not definitively rule out pathology if symptoms persist, particularly in women at risk for endometrial disease, as stated by the American College of Obstetricians and Gynecologists 1
Pipelle devices demonstrate high sensitivity (99.6%) for detecting endometrial carcinoma, but blind sampling can miss focal lesions, as reported by the American College of Obstetricians and Gynecologists 1

The American College of Obstetricians and Gynecologists recommends continuing the current progestin-only pill and counseling the patient that irregular bleeding typically improves after 3-6 months of continuous use 1
If bleeding persists beyond 3 months of OCP use or worsens, the National Comprehensive Cancer Network suggests escalating to hysteroscopy with directed biopsy 2, 1

The National Comprehensive Cancer Network indicates that persistent or recurrent bleeding despite 3+ months of hormonal management is an indication for hysteroscopy with directed biopsy 2, 1
The American College of Radiology recommends that hysteroscopy allows direct visualization and targeted biopsy of suspicious lesions, providing the highest diagnostic accuracy 4, 1

The Annals of Oncology suggest considering a levonorgestrel IUD, which provides excellent endometrial suppression and typically reduces bleeding over time 3
The Journal of the American College of Radiology recommends short-term use of NSAIDs or tranexamic acid during bleeding episodes to reduce blood loss while awaiting improvement in bleeding pattern 4